Table 3 Functional and pathway enrichment analysis of hsa-miR-9-5p related differentially expressed genes in Ovarian Cancer
Term | Description | Count | FDR |
|---|---|---|---|
Biological processes | |||
 GO:0032502 | developmental process | 46 | 0.0172 |
 GO:0048856 | anatomical structure development | 45 | 0.0316 |
 GO:0071840 | cellular component organization or biogenesis | 45 | 0.0199 |
 GO:0016043 | cellular component organization | 44 | 0.0266 |
 GO:0007275 | multicellular organism development | 42 | 0.0183 |
Molecular Function | |||
 GO:0005201 | extracellular matrix structural constituent | 5 | 0.0202 |
Cellular Component | |||
 GO:0030054 | cell junction | 16 | 0.0181 |
KEGG pathway | |||
 Hsa-1,474,244 | Extracellular matrix organization | 8 | 0.0417 |
 Hsa-422,475 | Axon guidance | 11 | 0.0459 |